Title: iRNA Agents Targeted to the Rho-A Gene
Patent Number: 7,772,200
Filed: July 21, 2006
Lead Inventor: Juergen Soutschek, Alnylam Pharmaceuticals
"The invention relates to compositions and methods for modulating the expression of the RhoA gene, and more particularly to the down-regulation of RhoA, by chemically modified oligonucleotides," the patent's abstract states.
Title: Highly Branched HK Peptides as Effective Carriers of siRNA